Table 4 Unadjusted and adjusted site, facility, patient, and management risks for artemisinin monotherapy (n = 273), India, 2008
From: Prescription practices and availability of artemisinin monotherapy in India: where do we stand?
| Â | Â | Â | Â | Unadjusted | Adjusted | ||
|---|---|---|---|---|---|---|---|
| Â | AM | Other | % | OR | 95%CI | OR | 95%CI |
State | Â | Â | Â | Â | Â | Â | Â |
Assam | 9 | 296 | 3.0 | -- | Â | -- | Â |
Goa | 1 | 217 | 0.5 | 0.2 | 0.0, 1.2 | 0.0 | 0.0, 0.4 |
Gujarat | 24 | 197 | 10.9 | 4.0 | 1.8, 8.9 | 0.9 | 0.3, 2.8 |
Delhi | 24 | 293 | 7.6 | 2.7 | 1.2, 5.9 | 5.4 | 1.7, 18 |
Jharkhand | 185 | 266 | 41.0 | 23 | 11, 49 | 5.5 | 2.1, 15 |
Orissa | 30 | 285 | 9.5 | 3.5 | 1.6, 7.5 | 0.3 | 0.1, 1.1 |
Facility type | Â | Â | Â | Â | Â | Â | Â |
Hospital | 240 | 1, 139 | 17.4 | -- | Â | -- | Â |
Primary clinic | 33 | 415 | 7.4 | 0.4 | 0.3, 0.6 | 0.6 | 0.3, 1.1 |
Age | Â | Â | Â | Â | Â | Â | Â |
< 15 yrs | 63 | 444 | 12.4 | -- | Â | -- | Â |
≥15 yrs | 209 | 1105 | 15.9 | 1.3 | 1.0, 1.8 | 1.8 | 1.2, 2.9 |
Sex | Â | Â | Â | Â | Â | Â | Â |
Male | 150 | 957 | 13.6 | -- | Â | -- | Â |
Female | 123 | 597 | 17.1 | 1.3 | 1.0, 1.7 | 0.8 | 0.6, 1.3 |
Sector | Â | Â | Â | Â | Â | Â | Â |
Government | 241 | 1357 | 15.1 | -- | Â | -- | Â |
Private | 32 | 197 | 14.0 | 0.9 | 0.6, 1.4 | 8.0 | 3.8, 17 |
Diagnosis | Â | Â | Â | Â | Â | Â | Â |
Blood Slide | 97 | 1, 122 | 8.0 | -- | Â | -- | Â |
RDK | 119 | 190 | 38.5 | 7.2 | 5.2, 10 | 1.5 | 0.9, 2.7 |
Both | 22 | 100 | 18.0 | 2.5 | 1.5, 4.2 | 1.8 | 0.9, 3.7 |
None | 35 | 129 | 21.3 | 2.9 | 1.9, 4.4 | Â | Â |
Result | Â | Â | Â | Â | Â | Â | Â |
Malaria positive | 194 | 621 | 23.8 | -- | Â | Â | Â |
Malaria negative | 36 | 503 | 6.7 | 0.2 | 0.2, 0.3 | Â | Â |
Unknown | 8 | 298 | 2.6 | 0.1 | 0.0, 0.2 | Â | Â |
Species | Â | Â | Â | Â | Â | Â | Â |
P. vivax | 18 | 306 | 5.6 | -- | Â | -- | Â |
P. falciparum | 166 | 305 | 35.2 | 9.3 | 5.4, 16 | 4.2 | 2.2, 7.8 |
Mixed infection | 4 | 6 | 40.0 | 11 | 2.8, 46 | 5.0 | 0.9, 28 |